Celanese Corp has a consensus price target of $151.36 based on the ratings of 22 analysts. The high is $184 issued by UBS on July 9, 2024. The low is $107 issued by Mizuho on January 12, 2023. The 3 most-recent analyst ratings were released by Keybanc, UBS, and Citigroup on July 10, 2024, July 9, 2024, and June 27, 2024, respectively. With an average price target of $170.67 between Keybanc, UBS, and Citigroup, there's an implied 22.56% upside for Celanese Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/10/2024 | Buy Now | 29.26% | Keybanc | Aleksey Yefremov | $190 → $180 | Maintains | Overweight | Get Alert |
07/09/2024 | Buy Now | 32.14% | UBS | Joshua Spector | $193 → $184 | Maintains | Buy | Get Alert |
06/27/2024 | Buy Now | 6.28% | Citigroup | Patrick Cunningham | $167 → $148 | Maintains | Neutral | Get Alert |
06/27/2024 | Buy Now | 29.26% | Wells Fargo | Michael Sison | $195 → $180 | Maintains | Overweight | Get Alert |
06/11/2024 | Buy Now | 13.46% | BMO Capital | John McNulty | $158 → $158 | Maintains | Market Perform | Get Alert |
06/10/2024 | Buy Now | 14.9% | Deutsche Bank | David Begleiter | $175 → $160 | Maintains | Hold | Get Alert |
06/10/2024 | Buy Now | 3.41% | B of A Securities | Steve Byrne | $147 → $144 | Maintains | Underperform | Get Alert |
05/17/2024 | Buy Now | 29.26% | Piper Sandler | Charles Neivert | $170 → $180 | Maintains | Overweight | Get Alert |
05/14/2024 | Buy Now | 13.46% | BMO Capital | John McNulty | $153 → $158 | Maintains | Market Perform | Get Alert |
05/13/2024 | Buy Now | 26.39% | RBC Capital | Arun Viswanathan | $171 → $176 | Maintains | Outperform | Get Alert |
05/10/2024 | Buy Now | 29.26% | Baird | Ghansham Panjabi | $165 → $180 | Maintains | Outperform | Get Alert |
05/09/2024 | Buy Now | 24.24% | Mizuho | Kieran De Brun | $161 → $173 | Maintains | Neutral | Get Alert |
04/19/2024 | Buy Now | 22.8% | RBC Capital | Arun Viswanathan | $165 → $171 | Maintains | Outperform | Get Alert |
04/10/2024 | Buy Now | 19.93% | Citigroup | Patrick Cunningham | $150 → $167 | Maintains | Neutral | Get Alert |
04/09/2024 | Buy Now | 36.45% | Keybanc | Aleksey Yefremov | $176 → $190 | Maintains | Overweight | Get Alert |
04/04/2024 | Buy Now | 22.08% | Barclays | Michael Leithead | $170 → $170 | Downgrade | Overweight → Equal-Weight | Get Alert |
04/04/2024 | Buy Now | 14.9% | JP Morgan | Jeffrey Zekauskas | $135 → $160 | Downgrade | Neutral → Underweight | Get Alert |
03/22/2024 | Buy Now | 40.04% | Wells Fargo | Michael Sison | $180 → $195 | Maintains | Overweight | Get Alert |
02/26/2024 | Buy Now | 18.49% | RBC Capital | Arun Viswanathan | $168 → $165 | Maintains | Outperform | Get Alert |
02/26/2024 | Buy Now | 22.08% | Piper Sandler | Charles Neivert | $135 → $170 | Upgrade | Neutral → Overweight | Get Alert |
02/22/2024 | Buy Now | 18.49% | Baird | Ghansham Panjabi | $135 → $165 | Maintains | Outperform | Get Alert |
02/22/2024 | Buy Now | 29.26% | Wells Fargo | Michael Sison | $167 → $180 | Maintains | Overweight | Get Alert |
01/22/2024 | Buy Now | 14.9% | Alembic Global | Hassan Ahmed | → $160 | Downgrade | Overweight → Neutral | Get Alert |
01/16/2024 | Buy Now | -3.05% | B of A Securities | Steve Byrne | $124 → $135 | Downgrade | Neutral → Underperform | Get Alert |
01/11/2024 | Buy Now | 22.08% | UBS | Joshua Spector | $169 → $170 | Maintains | Buy | Get Alert |
01/09/2024 | Buy Now | 26.39% | Keybanc | Aleksey Yefremov | $29 → $13 | Maintains | Overweight | Get Alert |
12/14/2023 | Buy Now | 21.36% | UBS | Joshua Spector | $144 → $169 | Maintains | Buy | Get Alert |
12/13/2023 | Buy Now | 4.13% | Citigroup | Patrick Cunningham | $130 → $145 | Maintains | Neutral | Get Alert |
11/21/2023 | Buy Now | -3.05% | Piper Sandler | Charles Neivert | → $135 | Upgrade | Underweight → Neutral | Get Alert |
11/08/2023 | Buy Now | 1.97% | RBC Capital | Arun Viswanathan | $145 → $142 | Maintains | Outperform | Get Alert |
10/04/2023 | Buy Now | -4.49% | Citigroup | Patrick Cunningham | $130 → $133 | Maintains | Neutral | Get Alert |
10/03/2023 | Buy Now | 7.72% | Keybanc | Aleksey Yefremov | $149 → $150 | Maintains | Overweight | Get Alert |
09/06/2023 | Buy Now | 7% | Keybanc | Aleksey Yefremov | → $149 | Upgrade | Sector Weight → Overweight | Get Alert |
08/29/2023 | Buy Now | -19.57% | Piper Sandler | Charles Neivert | $120 → $112 | Downgrade | Neutral → Underweight | Get Alert |
08/11/2023 | Buy Now | 11.31% | Barclays | Michael Leithead | $146 → $155 | Maintains | Overweight | Get Alert |
08/10/2023 | Buy Now | -6.64% | Citigroup | Patrick Cunningham | $123 → $130 | Maintains | Neutral | Get Alert |
08/10/2023 | Buy Now | 4.13% | RBC Capital | Arun Viswanathan | $128 → $145 | Maintains | Outperform | Get Alert |
08/09/2023 | Buy Now | -12.39% | JP Morgan | Jeffrey Zekauskas | $135 → $122 | Downgrade | Overweight → Neutral | Get Alert |
08/08/2023 | Buy Now | -20.29% | Credit Suisse | John Roberts | $100 → $111 | Maintains | Underperform | Get Alert |
07/19/2023 | Buy Now | -21.01% | Morgan Stanley | Vincent Andrews | $110 → $110 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/18/2023 | Buy Now | -0.9% | Wells Fargo | Michael Sison | $124 → $138 | Maintains | Overweight | Get Alert |
07/18/2023 | Buy Now | -10.23% | Deutsche Bank | David Begleiter | $120 → $125 | Downgrade | Buy → Hold | Get Alert |
07/12/2023 | Buy Now | -11.67% | Citigroup | Patrick Cunningham | $119 → $123 | Maintains | Neutral | Get Alert |
06/26/2023 | Buy Now | -14.54% | BMO Capital | John McNulty | $133 → $119 | Downgrade | Outperform → Market Perform | Get Alert |
06/22/2023 | Buy Now | -16.7% | B of A Securities | Matthew DeYoe | $123 → $116 | Downgrade | Buy → Neutral | Get Alert |
06/14/2023 | Buy Now | -14.54% | Citigroup | Patrick Cunningham | → $119 | Initiates | → Neutral | Get Alert |
06/09/2023 | Buy Now | -12.39% | Vertical Research | Kevin McCarthy | → $122 | Downgrade | Buy → Hold | Get Alert |
05/15/2023 | Buy Now | -13.82% | Deutsche Bank | David Begleiter | $135 → $120 | Maintains | Buy | Get Alert |
05/15/2023 | Buy Now | -5.92% | RBC Capital | Arun Viswanathan | → $131 | Reiterates | Outperform → Outperform | Get Alert |
05/12/2023 | Buy Now | -4.49% | BMO Capital | John McNulty | $146 → $133 | Maintains | Outperform | Get Alert |
05/11/2023 | Buy Now | -19.57% | Mizuho | Kieran De Brun | $113 → $112 | Maintains | Neutral | Get Alert |
05/11/2023 | Buy Now | -10.95% | Wells Fargo | Michael Sison | $140 → $124 | Maintains | Overweight | Get Alert |
05/11/2023 | Buy Now | 4.85% | Barclays | Michael Leithead | $150 → $146 | Maintains | Overweight | Get Alert |
05/10/2023 | Buy Now | -28.19% | Credit Suisse | John Roberts | → $100 | Reiterates | → Underperform | Get Alert |
04/12/2023 | Buy Now | -13.82% | Piper Sandler | Charles Neivert | $105 → $120 | Upgrade | Underweight → Neutral | Get Alert |
02/28/2023 | Buy Now | 4.85% | BMO Capital | John McNulty | $152 → $146 | Maintains | Outperform | Get Alert |
02/28/2023 | Buy Now | -5.92% | RBC Capital | Arun Viswanathan | $139 → $131 | Maintains | Outperform | Get Alert |
02/28/2023 | Buy Now | -18.85% | Mizuho | Kieran De Brun | $107 → $113 | Maintains | Neutral | Get Alert |
02/27/2023 | Buy Now | -3.05% | Deutsche Bank | David Begleiter | $105 → $135 | Maintains | Buy | Get Alert |
02/27/2023 | Buy Now | -6.64% | Baird | Ghansham Panjabi | $120 → $130 | Maintains | Outperform | Get Alert |
02/27/2023 | Buy Now | -13.11% | Citigroup | PJ Juvekar | $111 → $121 | Maintains | Neutral | Get Alert |
02/27/2023 | Buy Now | 0.54% | Wells Fargo | Michael Sison | $115 → $140 | Maintains | Overweight | Get Alert |
02/24/2023 | Buy Now | -28.19% | Credit Suisse | John Roberts | $83 → $100 | Maintains | Underperform | Get Alert |
01/12/2023 | Buy Now | -23.16% | Mizuho | Christopher Parkinson | $108 → $107 | Maintains | Neutral | Get Alert |
01/11/2023 | Buy Now | -3.05% | UBS | Joshua Spector | $124 → $135 | Maintains | Buy | Get Alert |
01/04/2023 | Buy Now | -10.23% | RBC Capital | Arun Viswanathan | $98 → $125 | Upgrade | Sector Perform → Outperform | Get Alert |
12/19/2022 | Buy Now | 7.72% | Barclays | Michael Leithead | $133 → $150 | Maintains | Overweight | Get Alert |
12/15/2022 | Buy Now | -20.29% | Citigroup | PJ Juvekar | $96 → $111 | Maintains | Neutral | Get Alert |
11/09/2022 | Buy Now | -6.64% | BMO Capital | John McNulty | $150 → $130 | Maintains | Outperform | Get Alert |
11/08/2022 | Buy Now | -22.44% | Mizuho | Kieran De Brun | $116 → $108 | Maintains | Neutral | Get Alert |
11/08/2022 | Buy Now | -29.62% | RBC Capital | Arun Viswanathan | $100 → $98 | Maintains | Sector Perform | Get Alert |
11/07/2022 | Buy Now | -31.06% | Citigroup | PJ Juvekar | $102 → $96 | Maintains | Neutral | Get Alert |
11/04/2022 | Buy Now | -40.39% | Credit Suisse | John Roberts | $86 → $83 | Maintains | Underperform | Get Alert |
10/18/2022 | Buy Now | -17.41% | Wells Fargo | Michael Sison | $130 → $115 | Maintains | Overweight | Get Alert |
10/12/2022 | Buy Now | -21.01% | Morgan Stanley | Vincent Andrews | $172 → $110 | Maintains | Equal-Weight | Get Alert |
10/11/2022 | Buy Now | -16.7% | Mizuho | Kieran De Brun | → $116 | Initiates | → Neutral | Get Alert |
10/10/2022 | Buy Now | -28.19% | Piper Sandler | Charles Neivert | $120 → $100 | Maintains | Underweight | Get Alert |
10/03/2022 | Buy Now | -21.01% | Deutsche Bank | David Begleiter | $140 → $110 | Maintains | Buy | Get Alert |
09/27/2022 | Buy Now | -6.64% | Wells Fargo | Michael Sison | $180 → $130 | Maintains | Overweight | Get Alert |
09/26/2022 | Buy Now | -38.24% | Credit Suisse | John Roberts | $105 → $86 | Maintains | Underperform | Get Alert |
08/02/2022 | Buy Now | 0.54% | Deutsche Bank | David Begleiter | $175 → $140 | Maintains | Buy | Get Alert |
08/02/2022 | Buy Now | 18.49% | Barclays | Michael Leithead | $190 → $165 | Maintains | Overweight | Get Alert |
08/01/2022 | Buy Now | -15.26% | Citigroup | PJ Juvekar | $143 → $118 | Downgrade | Buy → Neutral | Get Alert |
07/29/2022 | Buy Now | 17.06% | UBS | Joshua Spector | $166 → $163 | Maintains | Buy | Get Alert |
07/14/2022 | Buy Now | -15.26% | Fermium Research | Frank Mitsch | $130 → $118 | Maintains | Hold | Get Alert |
07/13/2022 | Buy Now | 3.41% | B of A Securities | Matthew DeYoe | $171 → $144 | Maintains | Neutral | Get Alert |
07/13/2022 | Buy Now | -16.7% | RBC Capital | Arun Viswanathan | $200 → $116 | Downgrade | Outperform → Sector Perform | Get Alert |
07/01/2022 | Buy Now | -6.64% | Fermium Research | Frank Mitsch | $165 → $130 | Maintains | Hold | Get Alert |
06/27/2022 | Buy Now | 29.26% | Wells Fargo | Michael Sison | $200 → $180 | Maintains | Overweight | Get Alert |
06/27/2022 | Buy Now | -24.6% | Credit Suisse | John Roberts | → $105 | Initiates | → Underperform | Get Alert |
05/18/2022 | Buy Now | 4.13% | Piper Sandler | Charles Neivert | $140 → $145 | Maintains | Underweight | Get Alert |
04/18/2022 | Buy Now | 24.96% | B of A Securities | Steve Byrne | $165 → $174 | Maintains | Neutral | Get Alert |
02/22/2022 | Buy Now | 25.67% | Deutsche Bank | David Begleiter | $185 → $175 | Maintains | Buy | Get Alert |
02/22/2022 | Buy Now | 0.54% | Piper Sandler | Charles Neivert | $180 → $140 | Downgrade | Neutral → Underweight | Get Alert |
02/16/2022 | Buy Now | 29.26% | Piper Sandler | Charles Neivert | $200 → $180 | Downgrade | Overweight → Neutral | Get Alert |
02/01/2022 | Buy Now | 47.94% | RBC Capital | Arun Viswanathan | $198 → $206 | Maintains | Outperform | Get Alert |
02/01/2022 | Buy Now | 43.63% | Wells Fargo | Michael Sison | $210 → $200 | Maintains | Overweight | Get Alert |
01/11/2022 | Buy Now | 23.52% | Morgan Stanley | Vincent Andrews | $157 → $172 | Maintains | Equal-Weight | Get Alert |
12/15/2021 | Buy Now | 23.52% | Goldman Sachs | — | — | Maintains | Neutral | Get Alert |
11/22/2021 | Buy Now | — | Keybanc | Aleksey Yefremov | — | Downgrade | Overweight → Sector Weight | Get Alert |
The latest price target for Celanese (NYSE:CE) was reported by Keybanc on July 10, 2024. The analyst firm set a price target for $180.00 expecting CE to rise to within 12 months (a possible 29.26% upside). 39 analyst firms have reported ratings in the last year.
The latest analyst rating for Celanese (NYSE:CE) was provided by Keybanc, and Celanese maintained their overweight rating.
The last upgrade for Celanese Corp happened on February 26, 2024 when Piper Sandler raised their price target to $170. Piper Sandler previously had a neutral for Celanese Corp.
The last downgrade for Celanese Corp happened on April 4, 2024 when Barclays changed their price target from $170 to $170 for Celanese Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celanese, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celanese was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
While ratings are subjective and will change, the latest Celanese (CE) rating was a maintained with a price target of $190.00 to $180.00. The current price Celanese (CE) is trading at is $139.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.